Technology | X-Ray | September 12, 2019

FDA Clears GE Healthcare's Critical Care Suite Chest X-ray AI

Platform includes first artificial intelligence algorithms embedded on-device to prioritize critical chest X-ray review

FDA Clears GE Healthcare's Critical Care Suite Chest X-ray AI

September 12, 2019 – GE Healthcare announced the U.S. Food and Drug Administration’s (FDA) 510(k) clearance of Critical Care Suite, a collection of artificial intelligence (AI) algorithms embedded on a mobile X-ray device. Built in collaboration with UC San Francisco (UCSF) using GE Healthcare’s Edison platform, the AI algorithms help to reduce the turn-around time it can take for radiologists to review a suspected pneumothorax, a type of collapsed lung.

A prioritized “STAT” X-ray can sit waiting for up to eight hours for a radiologist’s review[1]. However, when a patient is scanned on a device with Critical Care Suite, the system automatically analyzes the images by simultaneously searching for a pneumothorax. If a pneumothorax is suspected, an alert — along with the original chest X-ray — is sent directly to the radiologist for review via picture archiving and communication systems (PACS). The technologist also receives a subsequent on-device notification[2] to give awareness of the prioritized cases. Quality-focused AI algorithms simultaneously analyze and flag protocol and field-of-view errors as well as auto-rotate the images on-device. Critical Care Suite and the quality algorithms were developed using GE Healthcare’s Edison platform – which helps deploy AI algorithms quickly and securely – and deployed on the company’s Optima XR240amx system. 

“Clinicians are always looking for clinically proven methods to increase outcomes and improve the patient experience,” said Rachael Callcut, M.D., associate professor of surgery at UCSF, a surgeon at UCSF Health and director of data science for the Center for Digital Health Innovation, who partnered in the development of Critical Care Suite. “When a patient X-ray is taken, the minutes and hours it takes to process and interpret the image can impact the outcome in either direction. AI gives us an opportunity to speed up diagnosis and change the way we care for patients, which could ultimately save lives and improve outcomes.” 

Additionally, embedding Critical Care Suite on-device offers several benefits to radiologists and technologists. For critical findings, GE Healthcare’s algorithms are a fast and reliable way to ensure AI results are generated within seconds of image acquisition, without any dependency on connectivity or transfer speeds to produce the AI results. These results are then sent to the radiologist at the same time the device sends the original diagnostic image, ensuring no additional processing delay. Also, automatically running quality checks on-device integrates them into the technologist’s standard workflow and enables technologist actions – such as rejections or reprocessing – to occur at the patient’s bedside and before the images are sent to PACS. 

GE Healthcare’s Edison offering comprises applications and smart devices built using the Edison platform. The platform uses an extensive catalog of healthcare-specific developer services to enable both GE developers and select strategic partners to design, develop, manage, secure and distribute advanced applications, services and AI algorithms quickly. Edison integrates and assimilates data from multiple sources, applying analytics and AI to not only transform data, but provide actionable insights that can be deployed on medical devices, via the cloud or at the edge of the device. 

Additional partners in the development of Critical Care Suite include St. Luke’s University Health Network, Humber River Hospital and CARING - Mahajan Imaging – India. 

For more information: www.gehealthcare.com

References

1. Rachh P., Levey A.O., Lemmon A., et al. “Reducing STAT Portable Chest Radiograph Turnaround Times: A Pilot Study.” Current Problems in Diagnostic Radiology, published online June 5, 2017. https://doi.org/10.1067/j.cpradiol.2017.05.012

2. The technologist on-device notification is generated after a delay, post exam closure, and it does not provide any diagnostic information, nor is it intended to inform any clinical decision, prioritization, or action.

Related Content

A physician working in a coronavirus care center nearby Daegu, South Korea, is using Lunit INSIGHT CXR to interpret chest X-ray image of a coronavirus patient. Photo by Seoul National University Hospital

A physician working in a coronavirus care center nearby Daegu, South Korea, is using Lunit INSIGHT CXR to interpret chest X-ray image of a coronavirus patient. Photo by Seoul National University Hospital

News | Artificial Intelligence | March 30, 2020
March 30, 2020 — Lunit, a medical AI software company that dev
In the light of the coronavirus outbreak, MILabs has enhanced its line of high-performance CT scanners to even better detect the disease #COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2
News | Computed Tomography (CT) | March 27, 2020
March 27, 2020 — Based on recent scientific research, diagnostic X-ray...
CoronaCare is designed to help healthcare providers track COVID-19 (coronavirus) related symptoms of potentially infected patients. The platform enables communication with patients outside of facility walls and the ability to request the return of high-risk patients for more in-depth care. #COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2
News | Coronavirus (COVID-19) | March 27, 2020
March 27, 2020 — PaxeraHealth has spent years building and be
AI vendor Infervision's InferRead CT Pneumonia software uses artificial intelligence-assisted diagnosis to improve the overall efficiency of the radiology department. It is being developed in China as a high sensitivity detection aid for novel coronavirus pneumonia (COVID-19). #COVID19 #coronavirus #SARScov2

AI vendor Infervision's InferRead CT Pneumonia software uses artificial intelligence-assisted diagnosis to improve the overall efficiency of the radiology department. It is being developed in China as a high sensitivity detection aid for novel coronavirus pneumonia (COVID-19).

Feature | Coronavirus (COVID-19) | March 27, 2020 | Jilian Liu, M.D., HIMSS Greater China
An older couple walked into the Hubei Provincial Hospital of Integrated Chinese and Western Medicine near their neigh
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2
News | Artificial Intelligence | March 24, 2020
March 24, 2020 — Qure.ai, a leading healthcare...
Instant triage capability could potentially speed up diagnosis of COVID-19 individuals and ensure resources allocated properly.
News | Artificial Intelligence | March 23, 2020
March 23, 2020 — behold.ai announced that its artificial intellige
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

Representative examples of the attention heatmaps generated using Grad-CAM method for (a) COVID-19, (b) CAP, and (c) Non-Pneumonia. The heatmaps are standard Jet colormap and overlapped on the original image, the red color highlights the activation region associated with the predicted class. COVID-19 = coronavirus disease 2019, CAP = community acquired pneumonia. Image courtesy of the journal Radiology

News | Coronavirus (COVID-19) | March 20, 2020
March 20, 2020 — An arti...